ICAD
ICAD Inc
Price:  
3.87 
USD
Volume:  
190,074.00
United States | Health Care Technology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ICAD EV/EBITDA

-122.9%
Upside

As of 2025-10-11, the EV/EBITDA ratio of ICAD Inc (ICAD) is -17.32. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ICAD's latest enterprise value is 86.28 mil USD. ICAD's TTM EBITDA according to its financial statements is -4.98 mil USD. Dividing these 2 quantities gives us the above ICAD EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 4.7x - 11.7x 7.9x
Forward P/E multiples 4.7x - 14.2x 9.9x
Fair Price (0.12) - (1.40) (0.88)
Upside -103.1% - -136.1% -122.9%
3.87 USD
Stock Price
(0.88) USD
Fair Price

ICAD EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-16 -17.32
2025-07-15 -16.55
2025-07-14 -17.05